摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-dimethyl-5-nitro-6-styryluracil | 59119-41-4

中文名称
——
中文别名
——
英文名称
1,3-dimethyl-5-nitro-6-styryluracil
英文别名
1,3-dimethyl-5-nitro-6-styryl-1H-pyrimidine-2,4-dione;1,3-Dimethyl-5-nitro-6-(2-phenylethenyl)pyrimidine-2,4-dione
1,3-dimethyl-5-nitro-6-styryluracil化学式
CAS
59119-41-4
化学式
C14H13N3O4
mdl
——
分子量
287.275
InChiKey
LKYSNWSHWDHNJX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    196-198 °C(Solv: acetic acid (64-19-7); water (7732-18-5))
  • 沸点:
    406.3±55.0 °C(Predicted)
  • 密度:
    1.38±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    86.4
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,3-dimethyl-5-nitro-6-styryluracil 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 生成 5-amino-1,3-dimethyl-6-phenethyluracil
    参考文献:
    名称:
    Nishigaki, Sadao; Kanamori, Yukako; Senga, Keitaro, Chemical and pharmaceutical bulletin, 1980, vol. 28, # 5, p. 1636 - 1641
    摘要:
    DOI:
  • 作为产物:
    描述:
    1,3,4-三甲基尿嘧啶哌啶硫酸硝酸 作用下, 以 乙醇 为溶剂, 反应 5.0h, 生成 1,3-dimethyl-5-nitro-6-styryluracil
    参考文献:
    名称:
    Synthesis and Structure-Activity Relationships of Deazaxanthines: Analogs of Potent A1- and A2-Adenosine Receptor Antagonists
    摘要:
    A set of 22 9-deazaxanthines (pyrrolo[3,2-d]pyrimidine-2,4-diones) and three 7-deazaxanthines (pyrrolo[2,3-d] pyrimidine-2,4-diones) with various substituents in the 1-, 3-, 7- or 9-, and 8-positions was synthesized and investigated in A1 and A2a adenosine receptor binding assays at rat brain cortical membranes and rat brain striatal membranes, respectively. 9-Deazaxanthines showed structure-activity relationships that were similar to those of xanthines. They were about equipotent to the corresponding xanthines at A2a adenosine receptors. 9-Deazaxanthines were generally at least 2-3-fold more potent than xanthines at A1 receptors and therefore exhibited higher A1 selectivities compared to the xanthines. 1,3-Dimethyl-8-(2-naphthyl)-9-deazaxanthine (19e) showed high affinty (K-i = 26 nM) and selectivity for A1 adenosine receptors. A hydroxyl function at N7 of 9-deazaxanthines was unfavorable for A1 and A2a receptor binding. 7-Deazaxanthines were considerably less potent compared to xanthines and to 9-deazaxanthines at both receptor subtypes.
    DOI:
    10.1021/jm00036a019
点击查看最新优质反应信息

文献信息

  • Syntheses and properties of 3-hydroxy-4,6-dimethylpyrrolo(3,2-d)pyrimidine-5,7(4H,6H)-dione (9-hydroxy-9-deazatheophylline) derivatives.
    作者:FUMIO YONEDA、MIYUKI MOTOKURA、MUTSUKO KAMISHIMOTO、TOMOHISA NAGAMATSU、MASAKI OTAGIRI、KANETO UEKAMA、MASAYUKI TAKAMOTO
    DOI:10.1248/cpb.30.3187
    日期:——
    Treatment of 1, 3, 6-trimethyl-5-nitrouracil with aryl aldehydes in the presence of piperidine results in condensation to the 5-nitro-6-styryluracil derivatives, followed by intramolecular cyclization including piperidine-catalyzed oxidation-reduction to give rise to the corresponding 3-hydroxy-4, 6-dimethylpyrrolo [3, 2-d] pyrimidine-5, 7 (4H, 6H)-dione (9-hydroxy-9-deazatheophylline) derivatives in a single step. Some properties of these compounds and an X-ray crystal structure determination of 8-(p-chlorophenyl)-9-methoxy-7-methyl-9-deazatheophylline are described.
    1,3,6-三甲基-5-硝基尿嘧啶与芳基醛在哌啶存在下进行处理,缩合生成 5-硝基-6-苯乙烯基尿嘧啶衍生物、然后通过分子内环化(包括哌啶催化的氧化还原),一步生成相应的 3-羟基-4, 6-二甲基吡咯并[3, 2-d] 嘧啶-5, 7 (4H, 6H)-二酮(9-羟基-9-去氮茶碱)衍生物。文中介绍了这些化合物的一些特性以及 8-(对氯苯基)-9-甲氧基-7-甲基-9-去氮茶碱的 X 射线晶体结构。
  • Pyrimidine derivatives and related compounds. Part 36. Nucleophilic addition reaction of a cyanide lon to 6-substituted 1,3-dimethyl-5-nitrouracils. Synthesis of 5,6-dihydrouracil and 5,6-dihydrocyclo-thymine derivatives
    作者:Kosaku Hirota、Yoshihiro Yamada、Tetsuji Asao、Shigeo Senda
    DOI:10.1039/p19810001896
    日期:——
    6-Substituted 1,3-dimethyl-5-nitrouracils (3a–c) react with potassium cyanide to give stereospecifically the 6-cyano-5-nitro-5,6-dihydrouracils (4a–c). Reaction of 6-bromomethyl-1,3-dimethyl-5-nitrouracil (7) with potassium cyanide gives 6-cyano-1,3-dimethyl-5-nitro-5,6-dihydrocyclothymine (8). The structures of the 5,6-dihydrouracils (4a–c) and the cyclothymine (8) were clarified using 1H and 13C
    6-取代的1,3-二甲基-5-硝基尿嘧啶(3a–c)与氰化钾反应生成立体定向的6-氰基-5-硝基-5,6-二氢尿嘧啶(4a–c)。使6-溴甲基-1,3-二甲基-5-硝基尿嘧啶(7)与氰化钾反应,得到6-氰基-1,3-二甲基-5-硝基-5,6-二氢环胸腺嘧啶(8)。使用1 H和13 C核磁共振波谱对5,6-二氢尿嘧啶(4a–c)和环胸腺嘧啶(8)的结构进行了澄清。
  • NEW SYNTHESIS OF 1,3-DIMETHYL-7-HYDROXYPYRROLO[3,2-<i>d</i>]PYRIMIDINE-2,4(1<i>H</i>,3<i>H</i>)-DIONES (9-HYDROXY-9-DEAZATHEOPHYLLINES)
    作者:Fumio Yoneda、Miyuki Motokura、Masaki Otagiri
    DOI:10.1246/cl.1981.1273
    日期:1981.9.5
    Treatment of 5-nitro-1,3,6-trinitrouracil with aryl aldehydes in the presence of piperidine causes the condensation to the 5-nitro-6-styryluracil derivatives, followed by the intramolecular cyclization including piperidine-catalyzed oxidation-reduction to give rise to the corresponding 1,3-dimethyl-7-hydroxypyrrolo[3,2-d]pyrimidine-2,4(1H,3H)-dione (9-hydroxy-9-deazatheophylline) derivatives in a single step. Some properties of these compounds are discussed.
    在有哌啶存在的情况下,5-硝基-1,3,6-三硝基尿嘧啶与芳基醛处理后会缩合成 5-硝基-6-苯乙烯基尿嘧啶衍生物、然后通过分子内环化(包括哌啶催化的氧化还原),一步生成相应的 1,3-二甲基-7-羟基吡咯并[3,2-d]嘧啶-2,4(1H,3H)-二酮(9-羟基-9-去氮茶碱)衍生物。本文讨论了这些化合物的一些特性。
  • 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: Design, synthesis, structure–affinity and structure–selectivity relationships
    作者:Angela Stefanachi、Orazio Nicolotti、Francesco Leonetti、Saverio Cellamare、Francesco Campagna、Maria Isabel Loza、Jose Manuel Brea、Fernando Mazza、Enrico Gavuzzo、Angelo Carotti
    DOI:10.1016/j.bmc.2008.09.067
    日期:2008.11
    A number of 1,3-dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines were prepared and evaluated as ligands of recombinant human adenosine receptors (hARs). Several 1,3-dipropyl derivatives endowed with nano-molar binding affinity at hA(2B) receptors, but poor selectivity over hA(2A), hA(1) and hA(3) AR subtypes were identified. A comparison with the corresponding 7-OH- and 7,9-unsubstituted-deazaxanthines revealed that 9-OH-9-deazaxanthines are more potent hA(2B) ligands with lower partition coefficients and higher water solubility compared to the other two congeneric classes of deazaxanthines. An optimization of the para-substituent of the 8-phenyl ring of 9-OH-9-deazaxanthines led to the discovery of compound 38, which exhibited outstanding hA(2B) affinity (Ki = 1.0 nM), good selectivity over hA(2A), hA(1) and hA(3) (selectivity indices = 100, 79 and 1290, respectively) and excellent antagonist potency in a functional assay on rat A(2B) (pA(2B) = 9.33). (C) 2008 Published by Elsevier Ltd.
  • Synthesis and Structure-Activity Relationships of Deazaxanthines: Analogs of Potent A1- and A2-Adenosine Receptor Antagonists
    作者:Bettina Grahner、Susanne Winiwarter、Wolfgang Lanzner、Christa E. Mueller
    DOI:10.1021/jm00036a019
    日期:1994.5
    A set of 22 9-deazaxanthines (pyrrolo[3,2-d]pyrimidine-2,4-diones) and three 7-deazaxanthines (pyrrolo[2,3-d] pyrimidine-2,4-diones) with various substituents in the 1-, 3-, 7- or 9-, and 8-positions was synthesized and investigated in A1 and A2a adenosine receptor binding assays at rat brain cortical membranes and rat brain striatal membranes, respectively. 9-Deazaxanthines showed structure-activity relationships that were similar to those of xanthines. They were about equipotent to the corresponding xanthines at A2a adenosine receptors. 9-Deazaxanthines were generally at least 2-3-fold more potent than xanthines at A1 receptors and therefore exhibited higher A1 selectivities compared to the xanthines. 1,3-Dimethyl-8-(2-naphthyl)-9-deazaxanthine (19e) showed high affinty (K-i = 26 nM) and selectivity for A1 adenosine receptors. A hydroxyl function at N7 of 9-deazaxanthines was unfavorable for A1 and A2a receptor binding. 7-Deazaxanthines were considerably less potent compared to xanthines and to 9-deazaxanthines at both receptor subtypes.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐